Supplied strictly for in-vitro and laboratory research. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher handling these materials per applicable regulations and safe lab practice.
Ipamorelin is a selective pentapeptide ghrelin-receptor agonist studied for its targeted stimulation of growth-hormone release with minimal effect on other hormones. That selectivity, with comparatively little impact on cortisol or prolactin, makes it a common reference compound in secretagogue research.
Developed by Novo Nordisk under the code NNC 26-0161 and derived from GHRP-1, ipamorelin was characterized in the late 1990s as one of the most selective growth-hormone secretagogues then known. Its clean selectivity profile, releasing growth hormone with limited off-target hormonal activity, is what distinguished it from earlier secretagogues in experimental models.
Ipamorelin has been studied in endocrine models for selective growth-hormone-secretagogue-receptor agonism, growth-hormone-pulse stimulation, and IGF-1 modulation. Its selectivity is the central research feature: it allows investigators to stimulate growth-hormone output while holding other endocrine variables relatively steady, which simplifies interpretation. As a defined and highly selective secretagogue, it functions as a clean comparator in studies of secretory signaling.
Manufactured in a controlled U.S. facility under strict compounding standards.
Every batch third-party tested with HPLC and mass spectrometry.
Orders dispatched same-day from our U.S. facility.
Reach out and get a response within minutes.
Everything you need to know about our products and processes.